Schedule 13G ownership disclosure

INDIVIOR PLC

Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") · CUSIP: G4766E116

Event date: 2025-03-11

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Madison Avenue International LP

    Shares: 7,438,153 · Class: 6%

  • Madison Avenue Partners, LP

    Shares: 7,438,153 · Class: 6%

  • EMAI Management, LLC

    Shares: 7,438,153 · Class: 6%

  • Madison Avenue GP, LLC

    Shares: 7,438,153 · Class: 6%

  • Caraway Jackson Investments LLC

    Shares: 7,438,153 · Class: 6%

  • Eli Samaha

    Shares: 7,438,153 · Class: 6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001013594-25-000395
Form type
SCHEDULE 13G
Filer
Indivior Pharmaceuticals, Inc.
CIK
CIK 1625297
Filed
Mar 18, 2025
Reporting period
Mar 11, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub